LON:BELL Belluscura (BELL) Share Price, News & Analysis → Must-See: Elon’s New Invention is Absolutely Insane (From InvestorPlace) (Ad) Free BELL Stock Alerts GBX 15.50 -1.25 (-7.46%) (As of 05/21/2024 ET) Add Compare Share Share Today's Range 14.50▼ 17.5050-Day Range 7.08▼ 2452-Week Range 7▼ 52Volume215,354 shsAverage Volume389,862 shsMarket Capitalization£25.58 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsStock AnalysisChartCompetitors Get Belluscura alerts: Email Address Ad Porter & CompanyThis military-backed stock “owns” AI marketThe AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. About BelluscuraBelluscura plc develops and commercialize oxygen related medical device products. The company offers X-PLOR, a modular portable oxygen concentrator. Belluscura plc was incorporated in 2015 and is based in London, the United Kingdom.Read More BELL Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BELL Stock News HeadlinesNo headlines for this company have been tracked by MarketBeat.com Receive BELL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Belluscura and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolLON:BELL CUSIPN/A CIKN/A Webwww.belluscura.com PhoneN/AFaxN/AEmployees24Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX (0.06) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income£-10,000,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-40.83% Return on Assets-18.19% Debt Debt-to-Equity Ratio0.44 Current Ratio8.89 Quick Ratio5.13 Sales & Book Value Annual Sales£1.20 million Price / Sales21.32 Cash FlowGBX 1.94 per share Price / Cash Flow8.00 Book ValueGBX 19 per share Price / Book0.82Miscellaneous Outstanding Shares165,030,000Free FloatN/AMarket Cap£25.58 million OptionableNot Optionable Beta0.86 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesMr. Robert Rauker (Age 59)CEO & Director Comp: $461.77kMr. Simon Neicheril (Age 65)CFO & Director Mr. Keith CookVice President of OperationsMr. Robert Fary (Age 66)Senior Vice President of Global Sales & Executive Director Mr. Jim ClementHead of Commercial StrategyKey CompetitorsIntelligent Ultrasound GroupLON:IUGInspiration Healthcare GroupLON:IHCAdvanced OncotherapyLON:AVOPolarean ImagingLON:POLXRUA Life SciencesLON:RUAView All Competitors BELL Stock Analysis - Frequently Asked Questions How have BELL shares performed in 2024? Belluscura's stock was trading at GBX 23 on January 1st, 2024. Since then, BELL shares have decreased by 32.6% and is now trading at GBX 15.50. View the best growth stocks for 2024 here. How do I buy shares of Belluscura? Shares of BELL stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:BELL) was last updated on 5/21/2024 by MarketBeat.com Staff From Our PartnersThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersNext President (Not Trump. Not Biden.)The Freeport SocietyWarren Buffett's "mystery stock"Stansberry ResearchNew Options need New Trading StrategiesNetpicksObama’s Forever Term [exposed]Porter & CompanyTrump’s second term “playbook” leaked?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Belluscura plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.